AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
62 hedge funds and large institutions have $31.8M invested in Asterias Biotherapeutics Inc. Series A in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 7 closing their positions.
Holders
62
Holders Change
-2
Holders Change %
-3.13%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
16
Reduced
13
Closed
7
Calls
$241K
Puts
$569K
Net Calls
-$328K
Net Calls Change
-$202K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$2.85M |
| 2 |
2
BlackRock
New York
|
$4.38M |
| 3 |
3
Group One Trading
Chicago,
Illinois
|
$114K |
| 4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$60K |
| 5 |
VF
5
Virtu Financial
New York
|
$50K |
